Ken Sato

6.5k total citations
314 papers, 4.3k citations indexed

About

Ken Sato is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ken Sato has authored 314 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hepatology, 94 papers in Epidemiology and 61 papers in Surgery. Recurrent topics in Ken Sato's work include Liver Disease Diagnosis and Treatment (69 papers), Hepatitis C virus research (39 papers) and Liver Disease and Transplantation (29 papers). Ken Sato is often cited by papers focused on Liver Disease Diagnosis and Treatment (69 papers), Hepatitis C virus research (39 papers) and Liver Disease and Transplantation (29 papers). Ken Sato collaborates with scholars based in Japan, United States and China. Ken Sato's co-authors include Satoru Kakizaki, Hitoshi Takagi, Masatomo Mori, Yuichi Yamazaki, Yo‐ichiro Otofuji, Norio Horiguchi, Zhenyu Yang, Naondo Sohara, Daichi Takizawa and Hirotaka Arai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Physical review. B, Condensed matter.

In The Last Decade

Ken Sato

281 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Sato Japan 36 1.5k 1.4k 710 640 477 314 4.3k
Graeme A. Macdonald Australia 38 3.3k 2.2× 1.9k 1.4× 906 1.3× 760 1.2× 475 1.0× 170 6.0k
Yoshihiro Kamada Japan 52 1.9k 1.3× 784 0.6× 1.4k 2.0× 738 1.2× 414 0.9× 377 10.1k
Marco Maggioni Italy 45 2.8k 1.9× 1.6k 1.2× 1.2k 1.7× 918 1.4× 600 1.3× 156 6.3k
David J. Lomas United Kingdom 37 1.6k 1.1× 993 0.7× 279 0.4× 1.4k 2.2× 294 0.6× 150 6.8k
K. Uéda Japan 37 1.7k 1.1× 1.8k 1.3× 463 0.7× 748 1.2× 308 0.6× 178 4.6k
Tohru Takahashi Japan 37 543 0.4× 288 0.2× 1.5k 2.2× 1.4k 2.2× 1.1k 2.3× 443 6.7k
Pasquale Esposito Italy 32 643 0.4× 189 0.1× 516 0.7× 908 1.4× 268 0.6× 218 3.6k
Jerrold S. Levine United States 43 552 0.4× 211 0.2× 1.8k 2.6× 708 1.1× 341 0.7× 190 7.0k
Richard Parker United Kingdom 39 2.8k 1.9× 962 0.7× 1.1k 1.6× 970 1.5× 262 0.5× 239 7.1k
Kazuhiro Yamamoto Japan 43 419 0.3× 128 0.1× 1.1k 1.5× 756 1.2× 182 0.4× 311 6.8k

Countries citing papers authored by Ken Sato

Since Specialization
Citations

This map shows the geographic impact of Ken Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Sato more than expected).

Fields of papers citing papers by Ken Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Sato. The network helps show where Ken Sato may publish in the future.

Co-authorship network of co-authors of Ken Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Sato. A scholar is included among the top collaborators of Ken Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Sato. Ken Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Hirohisa, et al.. (2025). Development of Detection Method Using Dried Blood Spot with Next-Generation Sequencing and LabDroid for Gene Doping Control. International Journal of Molecular Sciences. 26(13). 6129–6129.
3.
Sugasawa, Takehito, et al.. (2024). Whole Mitochondrial DNA Sequencing Using Fecal Samples from Domestic Dogs. Animals. 14(19). 2872–2872.
4.
Takigawa, Yuki, Hiromi Watanabe, Ken Sato, et al.. (2024). Successful ultrathin bronchoscopy with cryobiopsy for diagnosing and removing mucus plugs in allergic bronchopulmonary mycosis mimicking lung cancer. SHILAP Revista de lepidopterología. 12(4). e01359–e01359. 2 indexed citations
6.
Sato, Ken, Yuichi Yamazaki, Hiroki Tojima, et al.. (2022). Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy. SHILAP Revista de lepidopterología. 10(4). e05690–e05690. 2 indexed citations
7.
Nakamura, Ryosuke, Noriaki Arakawa, Yoïchi Tanaka, et al.. (2022). Significant association between HLA‐B*35:01 and onset of drug‐induced liver injury caused by Kampo medicines in Japanese patients. Hepatology Research. 53(5). 440–449. 5 indexed citations
8.
Ichihara, Eiki, Toshihide Yokoyama, Koji Inoue, et al.. (2022). The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study. Cancers. 14(24). 6184–6184. 4 indexed citations
9.
Maeda, Kazuya, Hajime Takikawa, Kenji Tsuji, et al.. (2022). Frequency of null genotypes of glutathione S‐transferase M1 and T1 in Japanese patients with drug‐induced liver injury. Hepatology Research. 52(10). 882–887. 3 indexed citations
10.
Saito, Naoto, Takashi Ueno, Takeshi Hatanaka, et al.. (2021). Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct‐acting antivirals. SHILAP Revista de lepidopterología. 2(1). e11–e11. 2 indexed citations
11.
Yuan, Pu‐Qing, S. Vincent Wu, Andreas Stengel, Ken Sato, & Yvette Taché. (2021). Activation of CRF1 receptors expressed in brainstem autonomic nuclei stimulates colonic enteric neurons and secreto‐motor function in male rats. Neurogastroenterology & Motility. 33(11). e14189–e14189. 3 indexed citations
13.
Hatanaka, Takeshi, Satoru Kakizaki, Hiroki Tojima, et al.. (2019). Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Hepatology Research. 50(3). 382–395. 23 indexed citations
14.
Ichihara, Eiki, Daijiro Harada, Koji Inoue, et al.. (2019). The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer. Lung Cancer. 139. 140–145. 74 indexed citations
15.
Tojima, Hiroki, Satoru Kakizaki, Takashi Hoshino, et al.. (2019). Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure. Hepatology Research. 50(3). 303–312. 5 indexed citations
16.
Tojima, Hiroki, Satoru Kakizaki, Yuichi Yamazaki, et al.. (2018). Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis. Digestive and Liver Disease. 51(2). 226–235. 16 indexed citations
17.
Sato, Ken, Masafumi Mizuide, Yasuyuki Shimoyama, et al.. (2015). A Prospective Randomized Controlled Trial of AJG522 versus Standard PEG + E as Bowel Preparation for Colonoscopy. BioMed Research International. 2015. 1–8. 6 indexed citations
18.
Yamanaka, Naoaki, et al.. (1995). Jitter Tolerant Usage Parameter Control Method for ATM-Based B-ISDN. IEICE Transactions on Communications. 78(4). 485–493. 2 indexed citations
19.
Watanabe, Atsushi, Satoru Okamoto, & Ken Sato. (1994). Optical Path Cross-Connect Node Architecture with High Modularity for Photonic Transport Networks. IEICE Transactions on Communications. 77(10). 1220–1229. 38 indexed citations
20.
Yamanaka, Naoaki, et al.. (1993). Usage parameter control and bandwidth allocation methods considering cell delay variation in ATM networks. IEICE Transactions on Communications. 270–279. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026